Metformin for Abdominal Aortic Aneurysm Growth Inhibition
Clinical trial NCT04224051 · UNKNOWN
Trial details
- NCT number
- NCT04224051
- Sponsor
- Uppsala University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-12
- Primary completion
- 2026-01-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.